Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 6213-6216, Vol. 67, No. 11
Dipartimento di Produzioni Animali,
Received 17 May 1999/Returned for modification 23 June
1999/Accepted 9 August 1999
A major surface antigenic lipoprotein of Mycoplasma
agalactiae, promptly recognized by the host's immune system, was
characterized. The mature product, P48, showed significant similarity
and shared conserved amino acid motifs with lipoproteins or predicted
lipoproteins from Mycoplasma fermentans, Mycoplasma
hyorhinis, relapsing fever Borrelia spp.,
Bacillus subtilis, and Treponema pallidum.
Mycoplasma agalactiae is
the etiologic agent of contagious agalactia (CA) of sheep and goats, a
disease involving acute mastitis, arthritis, keratoconjunctivitis, and
abortion when first introduced in a susceptible population. In areas of
endemicity, symptoms are usually reduced to a subacute, sometimes
silent, mastitis with rare articular and ocular lesions. Once
established in a flock, M. agalactiae colonizes several host
tissues and can be recovered from apparently healthy animals even
several years after the first outbreak of the disease and/or the last
clinical episode. In the last few years, several authors have described
mechanisms by which mycoplasmas may evade immune response. Of these,
the best understood entails the variability of membrane lipoproteins (4, 5, 7, 17, 18, 25-27, 31, 33, 34, 39-42), while others
involve the ability of membrane lipoproteins and lipopeptides to induce
the expression of up- and down-regulating cytokines (10, 16, 19,
21, 25).
Very little is known about surface antigens of M. agalactiae
and, although the closest related species A Triton X-114 fraction (6, 24) of a field isolate from an
outbreak of typical CA of sheep, MA7, was analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting, with sera from naturally and experimentally infected
sheep. Samples of whole organisms and aqueous and detergent phases were
normalized to the original volumes and separated by SDS-PAGE, blotted
on a nitrocellulose membrane, and visualized through India ink staining
(11) (Fig. 1A, lanes 1 to 3).
Western immunoblotting was performed with sera from naturally (Fig. 1A, lane 4) and experimentally infected sheep (Fig. 1B), as described elsewhere (8), in order to identify immunodominant membrane lipoproteins.
The Triton X-114 phase was resolved by SDS-PAGE and electroblotted on a
polyvinylidene difluoride membrane (BioRad), and protein bands were
visualized by Coomassie blue staining. The band of interest was cut and
the N-terminal sequence was determined by Edman degradation by using an
automated Applied Biosystems 477A gas-phase sequencer (Applied
Biosystems Inc., Foster City, Calif.); PTH-derivative amino acids were
identified by RP-high-performance liquid chromatography (Applied
Biosystems 120A). A 12-amino-acid residue sequence was obtained from
the N terminus of the 45- to 50-kDa membrane protein: AS(X)GDKYFKETE,
in which X could be a modified C residue. We then synthesized a
nondegenerate 24-residue oligonucleotide corresponding to the peptide
sequence DKYFKETE and designed based on the preferred codon use of
closely related mycoplasmas in order to avoid highly redundant
nucleotide sequences. The probe sequence was
5'GATAAATATTTTAAAGAAACTGAA3'.
The oligonucleotide was 3' tailing labeled with digoxigenin-dUTP
(Boehringer Mannheim) by using terminal transferase. The tailing
mixture contained dCTP in place of dATP in order to minimize the risk
of nonspecific annealing to AT-rich regions, which are a common feature
in mycoplasma DNA sequences. Genomic DNA was digested to completion
with a panel of restriction enzymes, in various combinations (Fig.
2), resolved by 0.8% agarose gel
electrophoresis and was capillary transferred to positively charged
nylon membranes (Boehringer Mannheim). Hybridization, washing, and
nonradioactive detection were done following the digoxigenin system
user's guide (Boehringer Mannheim). A 4.1-kb HindIII
fragment and a 6.6-kb PstI DNA fragment, identified by
Southern analysis, were gel purified and ligated into digested and
dephosphorylated pUC18 cloning vector (28). Positives clones
were identified by standard colony hybridization and confirmed by slot
blot hybridization with the same oligoprobe. Transformants were grown
on a selective medium, and maxi-preps of plasmid DNA were cycle
sequenced by using vector universal sequencing primers and
sequence-generated primers on an ABI 373 DNA sequencer (Applied
Biosystems) by the dideoxy chain termination method with fluorescence
dye terminators (Perkin-Elmer). We partially sequenced the 4.1-kb
HindIII fragment, with vector universal primers, and
located a specific partial open reading frame (ORF), consistent with
the results of N-terminal sequencing, 300 bp upstream of the 3'
terminus of the insert. The complete ORF was then sequenced in the
6.6-kb PstI fragment, which overlaps the former by 2 kb, with primers designed based on the previous sequence. A 4,521-bp sequence was obtained. Nucleotide and protein sequences were submitted to Orf-finder and BLAST sequence similarity searching (1, 2) at the National Center for Biotechnology Information (NCBI) web site
and to the ExPasy web site facilities of the Swiss Institute of
Bioinformatics (3). Conserved motifs identified by BLAST analysis were scanned in the SWISS-PROT database (43), and
protein sequences of interest were aligned by using CLUSTAL W (14,
35); the multiple alignment was analyzed by GeneDoc
(22).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
P48 Major Surface Antigen of Mycoplasma agalactiae Is
Homologous to a malp Product of Mycoplasma
fermentans and Belongs to a Selected Family of Bacterial
Lipoproteins
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
Mycoplasma bovis
and Mycoplasma fermentans (99.8 and 95.0% 16S rRNA
similarity, respectively) (23)
possess the above-mentioned
features, it has not yet been possible to identify related genes in
M. agalactiae. In previous studies, a 45- to 55-kDa major
antigen of M. agalactiae, promptly recognized among total
proteins by sera from naturally (36) or experimentally
(8) infected sheep, was shown to be a membrane protein
sensitive to trypsin treatment of whole cells (24, 36, 37).
The aim of this study was to identify the gene encoding it and predict
its possible role in the pathogenesis of CA.

View larger version (63K):
[in a new window]
FIG. 1.
Characterization of the major surface antigens of
M. agalactiae. (A) Total proteins (lane 1), soluble fraction
(lane 2), and a Triton X-114 phase fraction (lane 3) were separated by
SDS-PAGE, transferred to a nitrocellulose membrane, and India ink
stained (11). Detergent-phase membrane-bound proteins (lane
3) were also immunostained with serum of a symptomatic naturally
infected sheep (lane 4). (B) Immunoblotting of Triton X-114 phase
fractionated proteins from M. agalactiae with preimmune
sheep serum (lane 1) and after 9 days (lane 2), 24 days (lane 3), and
57 days (lane 4) of experimental infection (8).

View larger version (37K):
[in a new window]
FIG. 2.
Identification of the P48 gene in the M. agalactiae genome. (A) Typical results obtained by Southern
analysis. Genomic DNA (5 µg/well) was digested with BglII
and EcoRI (lane 1), EcoRI (lane 2),
XbaI (lane 3), PstI (lane 4),
HindIII (lane 5), and PstI and
HindIII (lane 6). After electrophoresis and capillary
transfer to a positively charged nylon membrane, digested DNA was
hybridized with a digoxigenin-labeled oligoprobe derived from the
N-terminal microsequencing of P48. Two overlapping fragments, namely
the 4-kb HindIII and 6.6-kb PstI fragments,
were gel purified, cloned in pUC18, and partially sequenced. (B)
Physical map and partial characterization of coding regions
corresponding to the 4-kb HindIII and 6.6-kb
PstI overlapping fragments. The P48 gene is a
malp (7) homolog and encodes a 22-residue leader
peptide (white box), followed by the mature P48 lipoprotein (right
dashed box). Another ORF (left dashed box) was found in opposite
orientation and encodes a putative 59-kDa homolog of the P63 ABC
transporter of M. fermentans. H, P, and E indicate
HindIII, PstI, and EcoRI
restriction sites, respectively.
The complete specific ORF nucleotide sequence corresponds to a
lipoprotein-encoding gene. A 48-kDa mature lipoprotein (P48) derives
from the cleavage of a typical leader peptide at the site VAASC
immediately upstream of the cysteine residue, which is presumably the
acylation site to which palmitate binds (32). Four UGA
codons, as in all organisms belonging to the genus
Mycoplasma, are translated into tryptophan. The termination
of transcription or translation occurs at the level of three in-frame
TAA stop codons followed by an imperfect inverted repeat sequence,
which presumably forms a hairpin-like secondary structure. Two ORFs
flank the P48 gene on the opposite strand, so that the hairpin
terminator presumably functions even in the opposite orientation for
the downstream ORF. The amino acid sequence was submitted to BLAST and
BLAST 2.0 (1, 2) at the NCBI web site, and a significant
similarity was found with two M. fermentans products and a
Mycoplasma arginini product. The former products, P48 and
Ag161, earlier described as human-derived tumor cell products,
activating the differentiation of monocytes (19) and
targeting homologue C'3 activation (20), respectively, are
encoded by the same M. fermentans gene, malp, which also encodes a macrophage-activating lipopeptide (MALP-2) (7). The latter, originally described as an M. arginini metastasis-promoting factor (38), has recently
been shown to be the P47 lipoprotein of Mycoplasma hyorhinis
(7). Nucleotide sequencing of the P48 gene flanking regions
confirmed the homology with malp. Indeed, although in
opposite orientations, both lie upstream from a putative ABC
transporter operon (7, 33), partially sequenced in this study. P48 also shows a lower degree of similarity (16% identical residue and 33% conserved substitutions) with the variable
adherence-associated antigen, P50 adhesin, of Mycoplasma
hominis (12, 13), but unlike P48, P50 is organized in
repetitive blocks of amino acid sequences (41, 42). This
organization is common to several surface lipoproteins of mycoplasmas
and mammal pathogens and is consistent with a characteristic
variability aimed at evading the immune response (4, 17, 25, 30,
31, 40). This study did not aim to identify variable expression
of surface antigens, but posttranscriptional and posttranslational
modification of P48 cannot be excluded a priori, as recently suggested
for its closest homolog, MALP-404 of M. fermentans
(7). On the basis of BLAST results, we identified two
conserved motifs, SFNQS and IGVD-DQ. Both motifs were used to scan for
a pattern in the SWISS-PROT database (43). Some of the
protein sequences carrying both motifs were aligned by using CLUSTAL W
(14, 35), and the multiple alignment was analyzed by GeneDoc
(22). A longer version of the former motif, SLA (selective
lipoprotein associated), distributed among selected lipoproteins, has
been recently identified by Calcutt et al. (7). The use of
two short motifs, SLA-1 (our shorter version of SLA) and SLA-2
(IGVD-DQ), led us to individuate a larger family of bacterial
lipoproteins or putative products bearing them (Table
1). In particular, P48 homologs, not
identified by SLA, were found in the complete genome sequences from
Mycoplasma genitalium (9) and Mycoplasma
pneumoniae (15) (MG040 and its M. pneumoniae
homolog). On the other hand, two related products identified by Calcutt
et al., namely the CD4+ T-cell-stimulating antigen (TCSA)
from Listeria monocytogenes and the P20 hypothetical
lipoprotein from Mycoplasma capricolum, were initially
excluded because of the apparent absence of SLA-2. Actually, the TCSA
published sequence is truncated immediately upstream of the site that
might contain the SLA-2 motif by the vector cloning site
(29). Nevertheless, it is noteworthy that, in the original
paper (29), the CD4+ T-cell-stimulating activity
of this product had been assigned to the published truncated version.
On the contrary, the hypothetical P20 lipoprotein from M. capricolum was excluded even if an analysis of its encoding
nucleotide sequence, retrieved from the GenBank database (accession no.
Z33368.1), confirmed its homology with P48 and related products. In
fact, (i) two partially overlapping additional ORFs downstream of the
P20-encoding sequence should encode SLA-2, and (ii) an ABC
transporter-encoding sequence is located immediately downstream from
the above-mentioned malp homolog sequence.
|
Further research will be necessary to understand whether the SLA-1 and SLA-2 conserved amino acid motifs identified in this study will be helpful in assigning a more specific biological function to the proteins bearing them. Calcutt et al. (7), who also identified the longer version of SLA-1, speculate about its possible involvement in autoimmune disease or in targeting posttranslational proteolytic processing.
Establishing relations with biological and immunomodulatory features of M. fermentans and M. hyorhinis homologs would help to clarify the role of P48 in CA pathogenesis. Moreover, analogies between the arthritogenic properties of M. agalactiae and M. fermentans could lead to CA being considered an animal model of human mycoplasma arthritis.
Nucleotide sequence accession number. The sequences reported in this paper were deposited in the EMBL database under accession no. AJ132423.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from MURST and Assessorato alla Programmazione, Regione Autonoma Sardegna, Progetto Biotecnologie.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Istituto di Patologia Speciale e Clinica Medica Veterinaria, Università degli Studi di Sassari, Facoltà di Medicina Veterinaria, Via Vienna 2, 07100 Sassari, Italy. Phone: 39 079 229449. Fax: 39 079 229451. E-mail: pittau{at}ssmain.uniss.it.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[Medline]. |
| 2. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 3. | Appel, R. D., A. Bairoch, and D. F. Hochstrasser. 1994. A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem. Sci. 19:258-260[Medline]. |
| 4. |
Behrens, A.,
M. Heller,
H. Kirchhoff,
D. Yogev, and R. Rosengarten.
1994.
A family of phase- and size-variant membrane surface lipoprotein antigens (Vsps) of Mycoplasma bovis.
Infect. Immun.
62:5075-5084 |
| 5. |
Behrens, A.,
M. Heller,
R. Rosenbusch, and H. Kirchhoff.
1996.
Immunoelectron microscopic localization of variable proteins on the surface of Mycoplasma bovis.
Microbiology
142:1863-1871 |
| 6. |
Bordier, C.
1981.
Phase separation of integral membrane proteins in Triton X-114 solution.
J. Biol. Chem.
256:1604-1607 |
| 7. |
Calcutt, M. J.,
M. F. Kim,
A. B. Karpas,
P. F. Muhlradt, and K. S. Wise.
1999.
Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
Infect. Immun.
67:760-771 |
| 8. | Contini, A., M. Pittau, C. Cuccuru, P. Marcello, P. Briguglio, and M. Fadda. 1989. Experimental infection of sheep with Mycoplasma agalactiae: studies of antibodies response. Note 1. Atti Soc. Ital. Sci. Vet. 43:1119-1123. |
| 9. |
Fraser, C. M.,
J. D. Gocayne,
O. White,
M. D. Adams,
R. A. Clayton,
R. D. Fleischmann,
C. J. Bult,
A. R. Kerlavage,
G. Sutton,
J. M. Kelley,
J. L. Fritchman,
J. F. Weidman,
K. V. Small,
M. Sandusky,
J. Fuhrmann,
D. Nguyen,
T. R. Utterback,
D. M. Saudek,
C. A. Phillips,
J. M. Merrick,
J. F. Tomb,
B. A. Dougherty,
K. F. Bott,
P. C. Hu,
T. S. Lucier,
S. N. Peterson,
H. O. Smith,
C. A. Hutchison III, and J. C. Venter.
1995.
The minimal gene complement of Mycoplasma genitalium.
Science
270:397-403 |
| 10. | Hall, R. E., S. Agarwal, D. P. Kestler, J. A. Cobb, K. M. Goldstein, and N.-S. Chang. 1996. cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product. Biochem. J. 319:919-927. |
| 11. | Hancock, K., and V. C. W. Tsang. 1983. India ink staining of proteins on nitrocellulose paper. Anal. Biochem. 133:157-162[Medline]. |
| 12. |
Henrich, B.,
R.-C. Feldmann, and U. Hadding.
1993.
Cytoadhesins of Mycoplasma hominis.
Infect. Immun.
61:2945-2951 |
| 13. | Henrich, B., A. Kitzerov, R.-C. Feldmann, H. Schaal, and U. Hadding. 1996. Repetitive elements of the Mycoplasma hominis adhesin p50 can be differentiated by monoclonal antibodies. Infect. Immun. 64:4027-4034[Abstract]. |
| 14. |
Higgins, D. G.,
A. J. Bleasby, and R. Fuchs.
1992.
CLUSTAL V: improved software for multiple sequence alignment.
Comput. Appl. Biosci.
8:189-191 |
| 15. |
Himmelreich, R.,
H. Hilbert,
H. Plagens,
E. Pirkl,
B.-C. Li, and R. Herrmann.
1996.
Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.
Nucleic Acids Res.
24:4420-4449 |
| 16. |
Kostyal, D. A.,
G. H. Butler, and D. H. Beezhold.
1994.
A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes.
Infect. Immun.
62:3793-3800 |
| 17. |
Lysnyansky, I.,
R. Rosengarten, and D. Yogev.
1996.
Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangements.
J. Bacteriol.
178:5395-5401 |
| 18. |
Markham, P. F.,
M. D. Glew,
K. G. Whithear, and I. D. Walker.
1993.
Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum.
Infect. Immun.
61:903-909 |
| 19. |
Matsumoto, M.,
M. Nishiguchi,
S. Kikkawa,
H. Nishimura,
S. Nagasawa, and T. Seya.
1998.
Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes.
J. Biol. Chem.
273:12407-12414 |
| 20. | Matsumoto, M., J. Takeda, N. Inoue, T. Hara, M. Hatanaka, K. Takahashi, S. Nagasawa, H. Akedo, and T. Seya. 1997. A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat. Med. 3:1266-1270[Medline]. |
| 21. |
Mühlradt, P. F.,
M. Kiess,
H. Meyer,
R. Süssmuth, and G. Jung.
1997.
Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
J. Exp. Med.
185:1951-1958 |
| 22. | Nicholas, K. B., H. B. Nicholas, Jr., and D. W. Deerfield, II. 1997. GeneDoc: analysis and visualization of genetic variation. EMBNEW.NEWS 4:14. |
| 23. |
Pettersson, B.,
M. Uhlén, and K. E. Johansson.
1996.
Phylogeny of some mycoplasmas from ruminants based on 16S rRNA sequences and definition of a new cluster within the hominis group.
Int. J. Syst. Bacteriol.
46:1093-1098 |
| 24. | Pittau, M., M. Fadda, P. Briguglio, S. Farina, A. Q. Carboni, and A. Contini. 1990. Triton X-114 phase fractionation of Mycoplasma agalactiae membrane proteins and affinity purification of specific antibodies. Atti Soc. Ital. Sci. Vet. 44:925-928. |
| 25. |
Razin, S.,
D. Yogev, and Y. Naot.
1998.
Molecular biology and pathogenicity of mycoplasmas.
Microbiol. Mol. Biol. Rev.
62:1094-1156 |
| 26. |
Rosengarten, R.,
A. Behrens,
A. Stetefeld,
M. Heller,
M. Ahrens,
K. Sachse,
D. Yogev, and H. Kirchhoff.
1994.
Antigen heterogeneity among isolates of Mycoplasma bovis is generated by high-frequency variation of diverse membrane surface proteins.
Infect. Immun.
62:5066-5074 |
| 27. |
Rosengarten, R., and K. S. Wise.
1991.
The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct variant lipoproteins generating high-frequency surface antigenic variation.
J. Bacteriol.
173:4782-4793 |
| 28. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 29. |
Sanderson, S.,
D. J. Campbell, and N. Shastri.
1995.
Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning.
J. Exp. Med.
182:1751-1757 |
| 30. |
Seifert, H. S., and M. So.
1988.
Genetic mechanisms of bacterial antigenic variation.
Microbiol. Rev.
52:327-336 |
| 31. | Simmons, W. I., C. Zuhua, J. I. Glass, J. W. Simecka, G. H. Cassel, and H. L. Watson. 1996. Sequence analysis of the chromosomal region around and within the V-1 encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect. Immun. 64:472-479[Abstract]. |
| 32. |
Sutcliffe, I. C., and R. R. Russell.
1995.
Lipoproteins of gram-positive bacteria.
J. Bacteriol.
177:1123-1128 |
| 33. |
Theiss, P., and K. S. Wise.
1997.
Localized frameshift mutation generates selective, high-frequency phase variation of a surface lipoprotein encoded by a mycoplasma ABC transporter operon.
J. Bacteriol.
179:4013-4022 |
| 34. |
Theiss, P.,
M. F. Kim, and K. S. Wise.
1993.
Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans.
Infect. Immun.
61:5123-5128 |
| 35. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 36. | Tola, S., D. Manunta, M. Cocco, F. Turrini, A. M. Rocchigiani, G. Idini, A. Angioi, and G. Leori. 1997. Characterization of membrane surface proteins of Mycoplasma agalactiae during natural infection. FEMS Microbiol. Lett. 154:355-362[Medline]. |
| 37. | Tola, S., G. Idini, D. Manunta, I. Casciano, A. M. Rocchigiani, A. Angioi, and G. Leori. 1996. Comparison of Mycoplasma agalactiae isolates by pulsed field gel electrophoresis, SDS-PAGE and immunoblotting. FEMS Microbiol. Lett. 143:259-265[Medline]. |
| 38. | Ushio, S., K. Iwaki, M. Taniai, T. Otha, S. Fukuda, K. Sugimura, and M. Kurimoto. 1995. Metastasis-promoting activity of a novel molecule, Ag 243-5, derived from mycoplasma, and the complete nucleotide sequence. Microbiol. Immunol. 39:393-400[Medline]. |
| 39. |
Yogev, D.,
D. Menaker,
K. Strutzberg,
S. Levisohn,
H. Kirchhoff,
K. H. Hinz, and R. Rosengarten.
1994.
A surface epitope undergoing high-frequency phase variation is shared by Mycoplasma gallisepticum and Mycoplasma bovis.
Infect. Immun.
62:4962-4968 |
| 40. |
Yogev, D.,
R. Watson-McKown,
R. Rosengarten,
J. Im, and K. S. Wise.
1995.
Increased structural and combinatorial diversity in an extended family of genes encoding Vlp surface proteins of Mycoplasma hyorhinis.
J. Bacteriol.
177:5636-5643 |
| 41. | Zhang, Q., and K. S. Wise. 1997. Localized reversible frameshift mutation in an adhesin gene confers a phase-variable adherence phenotype in mycoplasma. Mol. Microbiol. 25:859-869[Medline]. |
| 42. | Zhang, Q., and K. S. Wise. 1996. Molecular basis of size and antigenic variation of a Mycoplasma hominis adhesin encoded by divergent vaa genes. Infect. Immun. 64:2737-2744[Abstract]. |
| 43. |
Zhang, Z.,
A. A. Schäffer,
W. Miller,
T. L. Madden,
D. J. Lipman,
E. V. Koonin, and S. F. Altschul.
1998.
Protein sequence similarity searches using patterns as seeds.
Nucleic Acids Res.
26:3986-3990 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»